Treatment with IFN-α in corticosteroid-unresponsive asthma

Journal of Allergy and Clinical Immunology

Volumn 105, Issue 5, 2000, Pages 1035-1036

  Gratzl, Stephanie ^a   Palca, Astrid ^b   Schmitz, Michael ^b   Simon, Hans Uwe ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b High Altitude Clinic Davos Wolfgang   (Switzerland)

Author keywords

Asthma; Corticosteroid; IFN

Indexed keywords

ALPHA INTERFERON; CORTICOSTEROID; CYCLOSPORIN A; PREDNISOLONE; RECOMBINANT ALPHA2A INTERFERON;

ADULT; ARTICLE; ASTHMA; CASE REPORT; CORTICOSTEROID THERAPY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HEADACHE; HUMAN; PRIORITY JOURNAL; VOMITING;

EID: 0007892829     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2000.105317     Document Type: Article

References (5)

1. 1. Butterfield JH, Gleich GJ. Response of six patients with idiopathic hypereosinophilic syndrome to interferon alfa. J Allergy Clin Immunol 1994;94:1318-26.
2. -T cells associated with abnormal Fas expression and hypereosinophilia. J Exp Med 1996;183:1071-82.
3. 3. Simon HU, Plötz SG, Dummer R, Blaser K. Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia. N Engl J Med 1999;341:1112-20.
4. 4. Oehling AG, Akdis CA, Schapowal A, Blaser K, Schmitz M, Simon HU. Suppression of the immune system by oral glucocorticoid therapy in bronchial asthma. Allergy 1997;52:144-54.
5. 5. Grob JJ, Dreno B, de la Salmonière P, Delaunay M, Cupissol D, Guillot B, et al. Randomised trial of interferon α-2a as adjuvant therapy in resected primary melanoma thicker than 1.5 mm without clinically detectable node metastases. Lancet 1998;351:1905-10.